HEALTH WITH LIGHT

Acute respiratory infections in children

 

APPROVED

Head Doctor PICH № 6

E.A. Degtyareva, Academic RAES, D.Med.Sc.

NORTHERN ADMINISTRATIVE DISTRICT, MOSCOW.

PEDIATRIC CLINICAL HOSPITAL for INFECTIOUS DISEASES № 6

DEPARTMENT OF HEALTH

NORTHERN ADMINISTRATIVE DISTRICT

MOSCOW

REPORT of Clinical studies of individual physiotherapeutic device “DOCTOR LIGHT” in children with light forms of acute respiratory infections

Bacterial-viral acute respiratory infections are one of the frequent causes for hospitalization in pediatric infectious clinics. On admission, very often and without enough indications, antibiotic-therapy is used which in turn causes, among infants, disorder of their biocenosis, immune-suppression, allergic reactions.

Thus, the search for new alternative drug-free methods for treatment of light forms of ARVI, especially in the early stages in the form of rhino-pharyngitis, is an important goal for pediatrics.

The aim of the current study was the evaluation of clinical efficiency and convenience in the use of the physiotherapeutic device “DOCTOR LIGHT”, the expected therapeutic effect of which is based on the bactericidal action of blue light on the mucous membranes of the buccal cavity and throat in children with acute respiratory infections, in the form of ARVI and rhino-pharyngitis.

Materials and methods. The main group of observation was composed of 50 children of age 2 months to 4 years (average age 2.7 + 2.6 years); the control group - of 30 children of identical age groups (average age 3.4 + 2.8) with similiar infections. Diagnosis of rhino-pharyngitis on the background of ARVI in the main and control groups was confirmed by ENT (Ear, Nose & Throat) doctor.

Criteria for selection of children into the main and control groups were frequent bouts of ARVI in their history, consent of their parents to apply drug-free therapeutic methods of treatment and the presence of light form of ARVI without bacterial complications at the admission; 8 children of 2-3 months had fungal infections of the mucous membranes of the oral cavity.

As at admission, 30 (60%) children of the main group and 15 (50%) of the control group had light symptoms of intoxication (restlessness, weakness, headache) (Table 1). Sub-febrile fever was registered in 40 (80%) of the main group and in 20 (60%) of the control group; rhinitis with serous discharge, hyperemia of the throat, swelling of the arc and tonsils, as mentioned above, were registered in all (100%) the children.

Treatment of patients of the main group involved mono-therapy with application of the device “DOCTOR LIGHT” 4 times a day for 30 minutes before feeding. The control group of patients, being on admission before the start of the current study, was evaluated retrospectively by analysis of their histories and were treated with throat gargle of Chamomile solution twice daily and antibiotic-therapy (Amoxicillin, Ampicillin at doses as per age).

Evaluation of efficiency and convenience in treatment with the use of the device “DOCTOR LIGHT” in the children was based on dynamic observation on the 3rd and 7th days of treatment on admission.

Analysis were made of dynamics of symptoms of the infections (rhinitis with serous discharge, hyperemia of the throat, swelling of the arc and tonsils, cough, general condition, appetite and activity in suckling) and recorded in individual observation cards. The following system of evaluation was used: “+” with clear expression of symptom, “+/-” for slight expression of symptom, and “-” for absence of symptom.

Study results

As mentioned above, the basic diagnosis of the children selected for the experiment in both the main and control groups, were light forms of acute respiratory infections in the form of rhino-pharyngitis.

Table 1

Statistics for the children with light forms of acute respiratory infections, selected for the study

Groups

Main

(n=50)

Control

(n=30)

Age

2 months to

4 years

2.5 months to

4.5 years

Average age

2.9 + 2.6

3.4 + 2.8

Period on admission

 

6.4 + 2.3 days

6.4 + 2.3 days

Diagnosis

ARVI (Rhino-pharyngitis0

Oral Candidiasis

 

42

8

 

30

Sub-febrile fever

Symptoms of intoxication

Rhinitis

Swelling and hyperemia of throat

Cough

Fungal infection of mucous membranes of oral cavity

Laboratory signs of inflammation (leukocytosis, ESR)

38/76%

30/60%

42/84%

42/84%

30/60%

8/16%

 

40/80%

20/66.6%

18/60%

30/100%

30/100%

15/50%

-

 

22/73.3%

 

In 8 cases observed of premature babies below 2 months of age, the treatment was prescribed for fungal infection of the mucous membranes of the oral cavity.

On auscultation, 60% children were observed with hard breathing in the lungs; whilst the others had normal breathing. Laboratory blood tests registered leukocytosis - average 9.5 +/- 2.3 thousand, and increase in ESR (Erythrocyte Sedimentation Rate) - average 15.3 +/- 3.6 mm/hr.

In the majority of cases with the use of the device “DOCTOR LIGHT” in treatment of children in the main group, there was made an observation of clear improvement of all of the registered symptoms from the second day of treatment.

Same was observed in the control group (use of antibacterial therapy). However, in the control group, from the 3rd – 5th days of treatment there were observed complications associated with antibacterial therapy in the form of allergic reactions in 5 children (16.6%) – the appearance of a paste-like viscous stool in 4 of the children (13.3.%) (Table 2).

Laboratory data (Leukocytosis, ESR) of 50% of children in the main group and of 40% of children in the control group became normal by the 5th day of illness and by the 7th day in all (100%) of the children of the 2 groups in the study. Symptoms of oral candidiasis in 8 children disappeared by the 3rd day of observation without additional local therapy.

Notwithstanding the similarity in results of treatment in the main and control groups, the appearance of the above-mentioned complications in the control group required additional administration of anti-histamines and enzymes. This had its reflection in prolongation of the admission period (6.4 + 2.3 days and 8.6 + 1.9 days respectively) (Table 2).

Therefore it can be concluded that the application of the device “DOCTOR LIGHT” in treatment of children with light forms of ARVI, rhino-pharyngitis and oral candidiasis was sufficiently efficacious without use of drugs; children felt comfortable with it and there were no side effects.

Table 2.

Dynamics of symptoms with the use of the device “DOCTOR LIGHT” in treatment of children with light forms of ARVI

(Frequency of registration of symptom, %)

 

Main Group (50)

Control Group (30)

Symptoms

1st day\initial

7th day

1st day\initial

7th day

Cough

20

(42%)

2

(4%)

15

(50%)

7

(23%)

Rhinitis

42

(84%)

0

25

(83%)

8

(26.6%)

Sub-febrile fever

38

(76%)

0

20

(66.6%)

5

(16.6%)

Symptoms of intoxication

30

(60%)

0

18

(60%)

2

(6.6%)

Leukocytosis (thousand)

9.2 + 3.25

5.1 + 2.5

9.3 + 2.5

6.2+1.6

ESR (mm/hr)

15.3 + 2.6

7.8 + 2.2

14.8+1.8

9.2+1.6

 

All mothers of the children expressed the will to purchase such device for possible use at home. 

The application of the device “DOCTOR LIGHT” for treatment of light forms of ARVI was sufficient to ensure anti-inflammatory action; it ensured, in cases of light forms without complications, to do without antibiotic therapy; thereby, preventing accompanied complications; it improved the clinical course of recovery by reducing the period of admission as compared to children in the control group who were prescribed standard antibiotic therapy.

During the treatment there were no record of any side effect, allergic reaction or other symptoms of discomfort.

 CONCLUSION

  1. Results of clinical use of the physiotherapeutic device “DOCTOR LIGHT” confirms the benefits in use of the said device for treatment of light forms of ARVI and infections of the mucous membranes of the oral cavity as a complete efficient drug-free method of treatment and an alternative to antibacterial therapy.

  2. The physiotherapeutic device “DOCTOR LIGHT” has proved its anti-inflammatory action for use in pediatrics, thereby, reducing the period of hospitalization.

  3. No side effects or allergic reactions were observed during the use of the physiotherapeutic device “DOCTOR LIGHT” for the treatment.

Doctor-in-charge M.P. Maksarova

Head of Department E.B. Kruzhenkova

Prof. E.A. Degtyareva, Acad. RAES, D.Med.Sc.

 

 

Leave a comment

Please note, comments must be approved before they are published